Letosteine
![]() | |
Clinical data | |
---|---|
Trade names | Viscotiol |
Routes of administration | Oral (gastroresistant capsules) |
ATC code | R05CB09 (WHO) |
Identifiers | |
| |
Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
CAS Number |
53943-88-7 ![]() |
PubChem (CID) | 68707 |
DrugBank |
DB08939 ![]() |
ChemSpider |
61958 ![]() |
UNII |
6MVF9U95DW ![]() |
KEGG |
D07380 ![]() |
ChEBI |
CHEBI:88271 ![]() |
ECHA InfoCard | 100.053.509 |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.378 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.